| Antibody-Dependent Enhancement of Viral Infections R Kulkarni Dynamics of Immune Activation in Viral Diseases, 9-41, 2020 | 96 | 2020 |
| Emerging OP354-like P [8] rotaviruses have rapidly dispersed from Asia to other continents M Zeller, E Heylen, S Damanka, C Pietsch, C Donato, T Tamura, ... Molecular biology and evolution 32 (8), 2060-2071, 2015 | 37 | 2015 |
| Sequence analysis of VP7 and VP4 genes of G1P [8] rotaviruses circulating among diarrhoeic children in Pune, India: a comparison with Rotarix and RotaTeq vaccine strains R Kulkarni, R Arora, R Arora, SD Chitambar Vaccine 32, A75-A83, 2014 | 32 | 2014 |
| Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital. V Arankalle, A Kulkarni-Munje, R Kulkarni, S Palkar, R Patil, J Oswal, ... Frontiers in immunology 13, 928501-928501, 2022 | 17 | 2022 |
| Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA R Kulkarni, HP Patil, S Palkar, S Lalwani, AC Mishra, V Arankalle Journal of Virological Methods 287, 113996, 2021 | 17 | 2021 |
| Risk of transfusion‐associated dengue: screening of blood donors from Pune, western India R Kulkarni, D Tiraki, D Wani, AC Mishra, VA Arankalle Transfusion 59 (2), 458-462, 2019 | 15 | 2019 |
| Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India R Kulkarni, M Modak, M Gosavi, D Wani, AC Mishra, VA Arankalle Indian Journal of Medical Research 151 (1), 71-78, 2020 | 14 | 2020 |
| Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy N Malshe, SK Patnaik, S Lalwani, P Suryawanshi, R Kulkarni, S Mhaske, ... Infection, 1-7, 2022 | 13 | 2022 |
| Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants N Malshe, S Palkar, R Kulkarni, S Lalwani, AC Mishra, V Arankalle Vaccine 37 (11), 1443-1448, 2019 | 13 | 2019 |
| Characterization of GII. 4 noroviruses circulating among children with acute gastroenteritis in Pune, India: 2005–2013 R Kulkarni, A Patel, S Bhalla, P Chhabra, S Cherian, SD Chitambar Infection, Genetics and Evolution 37, 163-173, 2016 | 13 | 2016 |
| Seroprevalence of antibodies against GII. 4 norovirus among children in Pune, India R Kulkarni, K Lole, SD Chitambar Journal of medical virology 88 (9), 1636-1640, 2016 | 11 | 2016 |
| Seroepidemiology of respiratory syncytial virus in western India with special reference to appropriate age for infant vaccination VA Arankalle, R Kulkarni, N Malshe, S Palkar, S Lalwani, AC Mishra Journal of medical virology 91 (8), 1566-1570, 2019 | 9 | 2019 |
| Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test R Kulkarni, S Shrivastava, HP Patil, P Kore, P Rane, S Palkar, S Lalwani, ... Indian Journal of Medical Research 153 (5-6), 658-664, 2021 | 8 | 2021 |
| Age‐stratified anti‐HAV positivity in Pune, India after two decades: Has voluntary vaccination impacted overall exposure to HAV? V Arankalle, D Tiraki, R Kulkarni, S Palkar, N Malshe, S Lalwani, A Mishra Journal of viral hepatitis 26 (6), 757-760, 2019 | 8 | 2019 |
| Clinical, epidemiological, and molecular aspects of picornaviruses (entero, parecho) in acute gastroenteritis: A study from Pune (Maharashtra), Western India V Gopalkrishna, N Ganorkar, P Patil, G Hedda, S Ranshing, R Kulkarni Journal of Medical Virology 93 (6), 3590-3600, 2021 | 7 | 2021 |
| SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India PP Doke, ST Mhaske, G Oka, R Kulkarni, V Muley, AC Mishra, ... Frontiers in public health 10, 1040012, 2023 | 5 | 2023 |
| An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial A Saraf, R Gurjar, S Kaviraj, A Kulkarni, D Kumar, R Kulkarni, R Virkar, ... Nature Medicine, 1-10, 2024 | 2 | 2024 |
| Immunoglobulin G Subclass Response After Chikungunya Virus Infection HP Patil, M Gosavi, R Kulkarni, AC Mishra, VA Arankalle Viral Immunology 35 (6), 437-442, 2022 | 2 | 2022 |
| Insights into the Biology of Norovirus: The So-Called “Perfect” Human Pathogen R Kulkarni Emerging Human Viral Diseases, Volume II: Encephalitic, Gastroenteric, and …, 2024 | | 2024 |
| Hospital‐based norovirus surveillance in children< 5 years of age from 2017 to 2019 in India S Giri, P Chhabra, R Kulkarni, S Reju, SK Sabapathy, S Selvarajan, ... Journal of Medical Virology 96 (1), e29384, 2024 | | 2024 |
